The Ovarian Cancer National Alliance sends our sympathies to the family of Daniel K. Inouye, senator of Hawaii and a long-time supporter of women with ovarian cancer.
Senator Inouye was elected to nine consecutive terms in the Senate, where he chaired the Appropriations Committee from 2009 to 2012. Under his leadership, the Senate continued to fund the Ovarian Cancer Research Program (OCRP) as a stand-alone program. The OCRP’s unique method of funding ovarian cancer research has yielded tremendous breakthroughs in the fight against ovarian cancer, such as:
- a new treatment using nanoparticles to deliver diphtheria toxin-encoding DNA to ovarian cancer cells, leaving healthy cells unaffected;
- the discovery of a compound that potentially inhibits a form of ovarian cancer that makes up 40 percent of ovarian cancer tumors; and
- the finding that ovarian cancer cells are sensitive to glucose deprivation and resveratrol treatment.
The Alliance is grateful for Senator Inouye’s leadership and support of federal funding for ovarian cancer research and education.